Charles Rodman, MD
Vascular Surgery · Corpus Christi, TXNPI 1316002785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 27.1% of the total. 2025 is the largest year on record at $1,441, 5.2 times the $280 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in TX, where the typical reported total is $7,106.
Across 250 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Tactile Systems Technology Inc$1K
- Urgo Medical North America, LLC$1K
- Medtronic$511
- Bard Peripheral Vascular, Inc.$249
- Smith+Nephew$128
- plus $348 from 11 others
What the payments were for
- Food & beverage$4,998100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 39 | $1,353 |
| Tactile Systems Technology Inc | 83 | $1,314 |
| Urgo Medical North America, LLC | 76 | $1,094 |
| Medtronic(2 entities) | 19 | $511 |
| Bard Peripheral Vascular, Inc. | 10 | $249 |
| Smith+Nephew | 10 | $128 |
| Venclose Inc. | 1 | $67 |
| Biocompatibles, Inc. | 1 | $61 |
| Organogenesis Inc. | 1 | $48 |
| Mimedx Group, Inc. | 2 | $32 |
| Reprise Biomedical, Inc. | 2 | $27 |
| AbbVie | 1 | $27 |
| KCI USA, Inc. | 1 | $24 |
| Hartmann USA, Inc. | 1 | $22 |
| Hydrofera LLC | 1 | $17 |
| Kerecis Limited | 1 | $13 |
| Cashflow Solutions, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,998 in reported general payments places this provider in the 35th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 62 | $51 |
| Clindamycin Hcl | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Corpus Christi
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
- Thomas LohShenandoah$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.